Skip to main content
. Author manuscript; available in PMC: 2023 Apr 2.
Published in final edited form as: ACS Nano. 2020 Feb 3;14(2):1296–1318. doi: 10.1021/acsnano.9b04837

Table 1.

Comparison of Delivery Methods of Reprogramming Factors for Cell Reprogramming

methods biological physical chemical
advantages
  • applicable both in vitro and in vivo

  • applicable in vitro

  • applicable both in vitro and in vivo, ease of administration

  • high transfection efficiency

  • nonimmunogenic and no mutagenesis, low or no genetic integration

  • nonimmunogenic and no mutagenesis, no genetic integration

  • works well for difficult-to-transfect cells

  • deliver diverse cargos without size limitations

  • deliver diverse cargos without size limitations

  • rapid, instantaneous transfection

  • diverse biomaterials are available or can be specifically designed

  • targeted delivery and controlled release

limitations
  • limited to nucleic acid delivery

  • less amenable to in vivo translation

  • low efficiency and slow delivery

  • limited packaging capacity

  • loss of cytoplasmic content

  • carrier materials may perturb cell function and/or cause toxicity in unpredictable ways

  • nonspecific target delivery in vivo

  • some approaches (e.g., bulk electroporation) can lead to excessive cell damage, highly stochastic transfection, and low efficiency

  • complex, laborious, and expensive material synthesis is required for advanced smart carriers

  • time-consuming, laborious, expensive and technically challenging

  • requires special expertise and complex fabrication protocols to achieve dose control

  • biosafety issues related to cytotoxicity, mutagenesis for integrating viruses, and adverse host immune response